Skip to content

Investigating the endolift method in the treatment of primary axillary hyperhidrosis

Investigating the safety and effectiveness of the endolift method in the treatment of primary axillary hyperhidrosis

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200127046282N43
Enrollment
10
Registered
2024-06-15
Start date
2024-06-20
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Increased armpit sweating. Localized hyperhidrosis

Interventions

Intervention 1: Intervention group: The patient will receive an endolift session in the armpit area. Intervention 2: Control group: The patient will not receive any treatment.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 20-60 years Increased underarm sweating if the sweat spot determined by the iodine starch test is more than 5 cm Persistence of hyperhidrosis for more than 6 months

Exclusion criteria

Exclusion criteria: Using drugs that affect the amount of sweating, such as cholinergic, adrenergic, antidepressant, and antipsychotic drugs. Presence of secondary cause of sweating such as infection, malignancy and neurological disorders

Design outcomes

Primary

MeasureTime frame
Underarm sweat rate. Timepoint: The beginning of the study and 6 months after the end of the study. Method of measurement: Using Iodine starch test.

Secondary

MeasureTime frame
Side effects. Timepoint: One week after endolift. Method of measurement: Questionnaire and visit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSona Zare

Skin and Stem Cell Research Center of Tehran University of Medical Sciences

sonazarebio@gmail.com+98 21 2665 7438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026